Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

BACKGROUND: Placebo-controlled clinical trials have demonstrated the efficacy of tocilizumab (TCZ) for remission maintenance and glucocorticoid sparing in patients with giant cell arteritis (GCA). However, limited data exist on the effectiveness and safety of TCZ for GCA in real-world clinical pract...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: Unizony, Sebastian, McCulley, Timothy J., Spiera, Robert, Pei, Jinglan, Sidiropoulos, Paris N., Best, Jennie H., Birchwood, Christine, Pavlov, Andrey, Stone, John H.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7789742/
https://ncbi.nlm.nih.gov/pubmed/33407817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-02377-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados